Physician profile
Haley W Mccool
NPI 1841859998
$546.18
in general payments reported to CMS, 2019-2025
12 companies · $218 in 2025
The $218 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.01 · 2021: $15.78 · 2024: $298 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $323 · Education: $193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $323.44 |
| Education | $192.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $228.25 | 2024-2025 | Veozah |
| Pfizer INC. | $62.58 | 2025 | |
| Organon LLC | $50.80 | 2024 | |
| Astellas Pharma Global Development | $41.13 | 2025 | Veozah |
| Baxter Healthcare | $33.27 | 2025 | Perclot |
| Channel Medsystems, INC. | $30.80 | 2025 | |
| Medtronic, INC. | $22.88 | 2025 | Truclear |
| Meditrina | $18.97 | 2024-2025 | |
| Abbvie INC. | $15.78 | 2021 | |
| Amag Pharmaceuticals, INC. | $14.01 | 2019 | |
| Sage Therapeutics, LLC | $13.91 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.80 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Mccool listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.